Skip to main content

Type-1 Cannabinoid Receptor

  • Reference work entry
  • First Online:
  • 91 Accesses

Synonyms

CANN6; CB1A; CB1K5; CB1R; CB-R; Central cannabinoid receptor

Historical Background

The use of cannabis (Cannabis sativa) has been known for centuries, but it was necessary to wait until the late 1980s to understand the molecular basis responsible for its medical and recreational properties. Unlike cocaine and morphine, isolated as crystalline salts from coca leaves and opium respectively, the active constituent of cannabis appeared as an oily extract, difficult to isolate in pure form. Only in the 1960s isolation, characterization, and chemical synthesis of the active cannabis constituent, Δ9-tetrahydrocannabinol (THC), was possible. The identification of THC allowed a reevaluation of cannabis pharmacology and gradually boosted research towards the understanding of the molecular and cellular mechanisms underlying its therapeutic efficacy.

Although the existence of THC-binding cannabinoid receptors, and of an even more surprising ensamble of metabolic enzymes and transporters...

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   4,499.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   4,499.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Bagher AM, Laprairie RB, Kelly ME, Denovan-Wright EM. Antagonism of dopamine receptor 2 long affects cannabinoid receptor 1 signaling in a cell culture model of striatal medium spiny projection neurons. Mol Pharmacol. 2016;89:652–66.

    Article  PubMed  CAS  Google Scholar 

  • Buraczynska M, Wacinski P, Zukowski P, Dragan M, Ksiazek A. Common polymorphism in the cannabinoid type 1 receptor gene (CNR1) is associated with microvascular complications in type 2 diabetes. J Diabetes Complications. 2014;28:35–9.

    Article  PubMed  Google Scholar 

  • Bushlin I, Gupta A, Stockton Jr SD, Miller LK, Devi LA. Dimerization with cannabinoid receptors allosterically modulates delta opioid receptor activity during neuropathic pain. PLoS One. 2012;7:e49789.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Chiodi V, Ferrante A, Ferraro L, Potenza RL, Armida M, Beggiato S, Pèzzola A, Bader M, Fuxe K, Popoli P, Domenici MR. Striatal adenosine-cannabinoid receptor interactions in rats over-expressing adenosine A2A receptors. J Neurochem. 2016;136:907–17.

    Article  PubMed  CAS  Google Scholar 

  • Ferré S, Casadó V, Devi LA, Filizola M, Jockers R, Lohse MJ, Milligan G, Pin JP, Guitart X. G protein-coupled receptor oligomerization revisited: functional and pharmacological perspectives. Pharmacol Rev. 2014;66:413–34.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Ferreira SG, Gonçalves FQ, Marques JM, Tomé ÂR, Rodrigues RJ, Nunes-Correia I, Ledent C, Harkany T, Venance L, Cunha RA, Köfalvi A. Presynaptic adenosine A2A receptors dampen cannabinoid CB1 receptor-mediated inhibition of corticostriatal glutamatergic transmission. Br J Pharmacol. 2015;172:1074–86.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Imperatore R, Palomba L, Morello G, Spiezio AD, Piscitelli F, Marzo VD, Cristino L. Formation of OX-1R/CB1R heteromeric complexes in embryonic mouse hypothalamic cells: Effect on intracellular calcium, 2-arachidonoyl-glycerol biosynthesis and ERK phosphorylation. Pharmacol Res. 2016;111:600–9.

    Article  PubMed  CAS  Google Scholar 

  • Hill SY, Jones BL, Steinhauer SR, Zezza N, Stiffler S. Longitudinal predictors of cannabis use and dependence in offspring from families at ultra high risk for alcohol dependence and in control families. Am J Med Genet B Neuropsychiatr Genet. 2016;171B:383–95.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Isir AB, Baransel C, Nacak M. An information theoretical study of the epistasis between the CNR1 1359 G/A polymorphism and the Taq1A and Taq1B DRD2 polymorphisms: assessing the susceptibility to cannabis addiction in a Turkish population. J Mol Neurosci. 2016;58:456–60.

    Article  PubMed  CAS  Google Scholar 

  • Jiang Y, Nie Y, Li Y, Zhang L. Association of cannabinoid type 1 receptor and fatty acid amide hydrolase genetic polymorphisms in Chinese patients with irritable bowel syndrome. J Gastroenterol Hepatol. 2014;29:1186–91.

    Article  PubMed  CAS  Google Scholar 

  • Kuliczkowska Plaksej J, Laczmanski L, Milewicz A, Lenarcik-Kabza A, Trzmiel-Bira A, Zaleska-Dorobisz U, Lwow F, Hirnle L. Cannabinoid receptor 1 gene polymorphisms and nonalcoholic fatty liver disease in women with polycystic ovary syndrome and in healthy controls. Int J Endocrinol. 2014;2014:232975.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Laprairie RB, Kelly ME, Denovan-Wright EM. The dynamic nature of type 1 cannabinoid receptor (CB(1)) gene transcription. Br J Pharmacol. 2012;167:1583–95.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature. 1990;346:561–4.

    Article  PubMed  CAS  Google Scholar 

  • Mechoulam R, Fride E, Di Marzo V. Endocannabinoids. Eur J Pharmacol. 1998;359:1–8.

    Article  PubMed  CAS  Google Scholar 

  • Pertwee RG, Howlett AC, Abood ME, Alexander SP, Di Marzo V, Elphick MR, Greasley PJ, Hansen HS, Kunos G, Mackie K, Mechoulam R, Ross RA. International union of basic and clinical pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2. Pharmacol Rev. 2010;62:588–631.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Rossi S, Bozzali M, Bari M, Mori F, Studer V, Motta C, Buttari F, Cercignani M, Gravina P, Mastrangelo N, Castelli M, Mancino R, Nucci C, Sottile F, Bernardini S, Maccarrone M, Centonze D. Association between a genetic variant of type-1 cannabinoid receptor and inflammatory neurodegeneration in multiple sclerosis. PLoS One. 2013;8:e82848.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Rozenfeld R, Bushlin I, Gomes I, Tzavaras N, Gupta A, Neves S, Battini L, Gusella GL, Lachmann A, Ma'ayan A, Blitzer RD, Devi LA. Receptor heteromerization expands the repertoire of cannabinoid signaling in rodent neurons. PLoS One. 2012;7:e29239.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Shim JY. Understanding functional residues of the cannabinoid CB1. Curr Top Med Chem. 2010;10:779–98.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Turu G, Hunyady L. Signal transduction of the CB1 cannabinoid receptor. J Mol Endocrinol. 2010;44:75–85.

    Article  PubMed  CAS  Google Scholar 

  • Vasileiou I, Fotopoulou G, Matzourani M, Patsouris E, Theocharis S. Evidence for the involvement of cannabinoid receptors’ polymorphisms in the pathophysiology of human diseases. Expert Opin Ther Targets. 2013;17:363–77.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Tiziana Bisogno or Mauro Maccarrone .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Bisogno, T., Maccarrone, M. (2018). Type-1 Cannabinoid Receptor. In: Choi, S. (eds) Encyclopedia of Signaling Molecules. Springer, Cham. https://doi.org/10.1007/978-3-319-67199-4_101565

Download citation

Publish with us

Policies and ethics